
PMC:3333881 / 45804-46069
Annnotations
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
22187158-19149660-77584483 | 158-160 | 19149660 | denotes | 76 |
22187158-19426715-77584484 | 161-163 | 19426715 | denotes | 77 |
pmc-enju-pas
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20893 | 0-5 | NN | denotes | NF-κB |
T20894 | 6-16 | NN | denotes | inhibitors |
T20895 | 16-17 | -COMMA- | denotes | , |
T20896 | 18-22 | JJ | denotes | such |
T20897 | 23-25 | IN | denotes | as |
T20898 | 26-39 | NN | denotes | anti-oxidants |
T20899 | 39-40 | -COMMA- | denotes | , |
T20900 | 41-51 | NN | denotes | proteasome |
T20901 | 52-55 | CC | denotes | and |
T20902 | 56-59 | NN | denotes | IKK |
T20903 | 60-70 | NN | denotes | inhibitors |
T20904 | 70-71 | -COMMA- | denotes | , |
T20905 | 72-85 | RB | denotes | significantly |
T20906 | 86-93 | VB | denotes | reduced |
T20907 | 94-97 | DT | denotes | the |
T20908 | 98-103 | NN | denotes | HIV-1 |
T20909 | 104-115 | NN | denotes | replication |
T20910 | 116-119 | CC | denotes | and |
T20911 | 120-123 | DT | denotes | the |
T20912 | 124-134 | VB | denotes | associated |
T20913 | 135-147 | JJ | denotes | inflammatory |
T20914 | 148-156 | NN | denotes | response |
T20915 | 157-158 | -LRB- | denotes | ( |
T20916 | 158-163 | CD | denotes | 76,77 |
T20917 | 163-164 | -RRB- | denotes | ) |
T20918 | 164-165 | -COLON- | denotes | ; |
T20919 | 166-173 | RB | denotes | however |
T20920 | 173-174 | -COMMA- | denotes | , |
T20921 | 175-180 | DT | denotes | these |
T20922 | 181-186 | NN | denotes | NF-κB |
T20923 | 187-197 | NN | denotes | inhibitors |
T20924 | 198-203 | VB | denotes | acted |
T20925 | 204-220 | RB | denotes | indiscriminately |
T20926 | 221-223 | IN | denotes | in |
T20927 | 224-228 | CC | denotes | both |
T20928 | 229-243 | JJ | denotes | HIV-1-infected |
T20929 | 244-247 | CC | denotes | and |
T20930 | 248-258 | JJ | denotes | uninfected |
T20931 | 259-264 | NN | denotes | cells |
R16861 | T20894 | T20893 | arg1Of | inhibitors,NF-κB |
R16862 | T20894 | T20895 | arg1Of | inhibitors,"," |
R16863 | T20894 | T20897 | arg1Of | inhibitors,as |
R16864 | T20894 | T20906 | arg1Of | inhibitors,reduced |
R16865 | T20897 | T20896 | arg1Of | as,such |
R16866 | T20898 | T20899 | arg1Of | anti-oxidants,"," |
R16867 | T20899 | T20901 | arg1Of | ",",and |
R16868 | T20900 | T20899 | arg2Of | proteasome,"," |
R16869 | T20901 | T20897 | arg2Of | and,as |
R16870 | T20903 | T20901 | arg2Of | inhibitors,and |
R16871 | T20903 | T20902 | arg1Of | inhibitors,IKK |
R16872 | T20906 | T20904 | arg1Of | reduced,"," |
R16873 | T20906 | T20905 | arg1Of | reduced,significantly |
R16874 | T20906 | T20918 | arg1Of | reduced,; |
R16875 | T20909 | T20907 | arg1Of | replication,the |
R16876 | T20909 | T20908 | arg1Of | replication,HIV-1 |
R16877 | T20909 | T20910 | arg1Of | replication,and |
R16878 | T20910 | T20906 | arg2Of | and,reduced |
R16879 | T20914 | T20910 | arg2Of | response,and |
R16880 | T20914 | T20911 | arg1Of | response,the |
R16881 | T20914 | T20912 | arg2Of | response,associated |
R16882 | T20914 | T20913 | arg1Of | response,inflammatory |
R16883 | T20914 | T20915 | arg1Of | response,( |
R16884 | T20916 | T20915 | arg2Of | "76,77",( |
R16885 | T20917 | T20915 | arg3Of | ),( |
R16886 | T20923 | T20921 | arg1Of | inhibitors,these |
R16887 | T20923 | T20922 | arg1Of | inhibitors,NF-κB |
R16888 | T20923 | T20924 | arg1Of | inhibitors,acted |
R16889 | T20924 | T20918 | arg2Of | acted,; |
R16890 | T20924 | T20919 | arg1Of | acted,however |
R16891 | T20924 | T20920 | arg1Of | acted,"," |
R16892 | T20924 | T20925 | arg1Of | acted,indiscriminately |
R16893 | T20924 | T20926 | arg1Of | acted,in |
R16894 | T20928 | T20929 | arg1Of | HIV-1-infected,and |
R16895 | T20929 | T20927 | arg1Of | and,both |
R16896 | T20930 | T20929 | arg2Of | uninfected,and |
R16897 | T20931 | T20926 | arg2Of | cells,in |
R16898 | T20931 | T20928 | arg1Of | cells,HIV-1-infected |
R16899 | T20931 | T20930 | arg1Of | cells,uninfected |
bionlp-st-ge-2016-spacy-parsed
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22261 | 0-5 | JJ | denotes | NF-κB |
T22262 | 6-16 | NNS | denotes | inhibitors |
T22263 | 16-17 | , | denotes | , |
T22264 | 18-22 | JJ | denotes | such |
T22265 | 23-25 | IN | denotes | as |
T22266 | 26-39 | NNS | denotes | anti-oxidants |
T22267 | 39-40 | , | denotes | , |
T22268 | 41-51 | JJ | denotes | proteasome |
T22269 | 52-55 | CC | denotes | and |
T22270 | 56-59 | NNP | denotes | IKK |
T22271 | 60-70 | NNS | denotes | inhibitors |
T22272 | 70-71 | , | denotes | , |
T22273 | 72-85 | RB | denotes | significantly |
T22274 | 86-93 | VBD | denotes | reduced |
T22275 | 94-97 | DT | denotes | the |
T22276 | 98-103 | NNP | denotes | HIV-1 |
T22277 | 104-115 | NN | denotes | replication |
T22278 | 116-119 | CC | denotes | and |
T22279 | 120-123 | DT | denotes | the |
T22280 | 124-134 | VBN | denotes | associated |
T22281 | 135-147 | JJ | denotes | inflammatory |
T22282 | 148-156 | NN | denotes | response |
T22283 | 157-158 | -LRB- | denotes | ( |
T22284 | 158-163 | CD | denotes | 76,77 |
T22285 | 163-164 | -RRB- | denotes | ) |
T22286 | 164-165 | : | denotes | ; |
T22287 | 166-173 | RB | denotes | however |
T22288 | 173-174 | , | denotes | , |
T22289 | 175-180 | DT | denotes | these |
T22290 | 181-186 | JJ | denotes | NF-κB |
T22291 | 187-197 | NNS | denotes | inhibitors |
T22292 | 198-203 | VBD | denotes | acted |
T22293 | 204-220 | RB | denotes | indiscriminately |
T22294 | 221-223 | IN | denotes | in |
T22295 | 224-228 | DT | denotes | both |
T22296 | 229-243 | JJ | denotes | HIV-1-infected |
T22297 | 244-247 | CC | denotes | and |
T22298 | 248-258 | JJ | denotes | uninfected |
T22299 | 259-264 | NNS | denotes | cells |
T22300 | 264-265 | . | denotes | . |
R17962 | T22271 | T22268 | conj | inhibitors,proteasome |
R17963 | T22272 | T22262 | punct | ",",inhibitors |
R17964 | T22273 | T22274 | advmod | significantly,reduced |
R17965 | T22274 | T22292 | ccomp | reduced,acted |
R17966 | T22275 | T22277 | det | the,replication |
R17967 | T22276 | T22277 | compound | HIV-1,replication |
R17968 | T22277 | T22274 | dobj | replication,reduced |
R17969 | T22278 | T22277 | cc | and,replication |
R17970 | T22279 | T22282 | det | the,response |
R17971 | T22280 | T22282 | amod | associated,response |
R17972 | T22281 | T22282 | amod | inflammatory,response |
R17973 | T22282 | T22277 | conj | response,replication |
R17974 | T22283 | T22282 | punct | (,response |
R17975 | T22284 | T22282 | appos | "76,77",response |
R17976 | T22285 | T22274 | punct | ),reduced |
R17977 | T22286 | T22292 | punct | ;,acted |
R17978 | T22287 | T22292 | advmod | however,acted |
R17979 | T22288 | T22292 | punct | ",",acted |
R17980 | T22289 | T22291 | det | these,inhibitors |
R17981 | T22290 | T22291 | amod | NF-κB,inhibitors |
R17982 | T22291 | T22292 | nsubj | inhibitors,acted |
R17983 | T22292 | T22292 | ROOT | acted,acted |
R17984 | T22293 | T22292 | advmod | indiscriminately,acted |
R17985 | T22294 | T22292 | prep | in,acted |
R17986 | T22295 | T22296 | preconj | both,HIV-1-infected |
R17987 | T22296 | T22299 | amod | HIV-1-infected,cells |
R17988 | T22297 | T22296 | cc | and,HIV-1-infected |
R17989 | T22298 | T22296 | conj | uninfected,HIV-1-infected |
R17990 | T22299 | T22294 | pobj | cells,in |
R17991 | T22300 | T22292 | punct | .,acted |
R17952 | T22261 | T22262 | amod | NF-κB,inhibitors |
R17953 | T22262 | T22274 | nsubj | inhibitors,reduced |
R17954 | T22263 | T22262 | punct | ",",inhibitors |
R17955 | T22264 | T22265 | amod | such,as |
R17956 | T22265 | T22262 | prep | as,inhibitors |
R17957 | T22266 | T22265 | pobj | anti-oxidants,as |
R17958 | T22267 | T22266 | punct | ",",anti-oxidants |
R17959 | T22268 | T22266 | conj | proteasome,anti-oxidants |
R17960 | T22269 | T22268 | cc | and,proteasome |
R17961 | T22270 | T22268 | conj | IKK,proteasome |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22344 | 56-59 | http://purl.obolibrary.org/obo/GO_0008384 | denotes | IKK |
T22355 | 0-16 | http://purl.obolibrary.org/obo/GO_0032088 | denotes | NF-κB inhibitors |
T22356 | 181-197 | http://purl.obolibrary.org/obo/GO_0032088 | denotes | NF-κB inhibitors |
T22357 | 0-16 | http://purl.obolibrary.org/obo/GO_0007252 | denotes | NF-κB inhibitors |
T22358 | 181-197 | http://purl.obolibrary.org/obo/GO_0007252 | denotes | NF-κB inhibitors |
T22359 | 135-156 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22367 | 56-59 | http://purl.obolibrary.org/obo/GO_0008384 | denotes | IKK |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22362 | 259-264 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T22363 | 41-51 | http://purl.obolibrary.org/obo/GO_0000502 | denotes | proteasome |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19909 | 0-265 | Sentence | denotes | NF-κB inhibitors, such as anti-oxidants, proteasome and IKK inhibitors, significantly reduced the HIV-1 replication and the associated inflammatory response (76,77); however, these NF-κB inhibitors acted indiscriminately in both HIV-1-infected and uninfected cells. |
T266 | 0-265 | Sentence | denotes | NF-κB inhibitors, such as anti-oxidants, proteasome and IKK inhibitors, significantly reduced the HIV-1 replication and the associated inflammatory response (76,77); however, these NF-κB inhibitors acted indiscriminately in both HIV-1-infected and uninfected cells. |
bionlp-st-ge-2016-reference-tees
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T23853 | 0-5 | Protein | denotes | NF-κB |
T23854 | 56-59 | Protein | denotes | IKK |
T23855 | 181-186 | Protein | denotes | NF-κB |
T23856 | 6-16 | Negative_regulation | denotes | inhibitors |
T23857 | 6-16 | Negative_regulation | denotes | inhibitors |
R19036 | T23853 | T23856 | themeOf | NF-κB,inhibitors |
R19037 | T23854 | T23857 | themeOf | IKK,inhibitors |